Related Experiment Video
Updated: Sep 8, 2025
Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Discovery and Characterization of Novel FGFR1 V561M Inhibitors via Virtual Screening and Molecular Dynamics
Yang Lu1, Bizhi Li2, Xiaoli Zheng1
1Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou 310015, China.
None:
The FGFR1 V561M mutation significantly reduces the efficacy of current FGFR1 inhibitors, creating an urgent need for targeted second-generation therapies. In this study, we developed a comprehensive virtual screening protocol that combines energy-based screening and machine learning techniques, leading to the identification of a novel compound, 1457983-28-6. This compound exhibited potent inhibitory activity against FGFR1 V561M with an IC50 of 90.24 nM in homogeneous time-resolved fluorescence (HTRF) bioassays. Additionally, it demonstrated significant growth inhibition in the Huh-7 cell line and effectively suppressed clonal formation. Molecular dynamics simulations revealed critical binding interactions between 1457983-28-6 and both FGFR1 wild-type and V561M variants, with Lys514 playing a pivotal role. Targeting this residue may provide promising strategies to overcome resistance associated with the V561M mutation in FGFR1 inhibitors.
More Related Videos
Related Concept Videos
01:26Drug Discovery: Overview
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...